MOLECULAR PSYCHIATRY

Scope & Guideline

Advancing the Frontiers of Mental Health Research

Introduction

Immerse yourself in the scholarly insights of MOLECULAR PSYCHIATRY with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1359-4184
PublisherSPRINGERNATURE
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationMOL PSYCHIATR / Mol. Psychiatr.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal "Molecular Psychiatry" focuses on the intersection of molecular biology and psychiatric disorders, examining the genetic, epigenetic, and neurobiological underpinnings of mental health conditions. It aims to provide a comprehensive understanding of how molecular mechanisms influence psychiatric phenotypes, treatment responses, and disease progression.
  1. Molecular Genetics and Genomics:
    Exploration of genetic variations, including single nucleotide polymorphisms (SNPs) and copy number variations, associated with psychiatric disorders, aiming to identify biomarkers for risk assessment and therapeutic targets.
  2. Neurodevelopmental Mechanisms:
    Investigation into how neurodevelopmental processes, including synaptic formation and plasticity, contribute to psychiatric conditions, with a focus on autism spectrum disorders and schizophrenia.
  3. Neuroinflammation and Immune Response:
    Study of the role of neuroinflammation and immune system dysregulation in the pathophysiology of mental disorders, linking peripheral immune markers to central nervous system changes.
  4. Neuroimaging and Biomarkers:
    Utilization of advanced neuroimaging techniques to identify structural and functional brain changes associated with psychiatric disorders, aiming to correlate these findings with clinical symptoms and treatment outcomes.
  5. Translational Research:
    Emphasis on translational studies that bridge the gap between basic neuroscience and clinical applications, including pharmacological interventions and therapeutic strategies.
  6. Environmental and Lifestyle Factors:
    Examination of how environmental stressors, lifestyle choices, and psychosocial factors interact with biological predispositions to influence mental health outcomes.
Recent publications in "Molecular Psychiatry" highlight several trending and emerging themes that are gaining significant attention in the field. These reflect advancements in technology, interdisciplinary approaches, and a deeper understanding of the complexities surrounding psychiatric disorders.
  1. Integrated Multi-Omics Approaches:
    There is an increasing trend towards the use of multi-omics strategies (genomics, transcriptomics, proteomics, metabolomics) to provide a more holistic understanding of psychiatric disorders, aiding in the identification of biomarkers and therapeutic targets.
  2. Neurodevelopmental and Neuroplasticity Research:
    Research focusing on the neurodevelopmental aspects of psychiatric disorders, particularly those related to synaptic plasticity and neurogenesis, is on the rise, emphasizing the dynamic nature of the brain in response to environmental and genetic factors.
  3. Role of the Gut-Brain Axis:
    Emerging studies are highlighting the significant role of the gut microbiome in influencing psychiatric outcomes, particularly regarding mood disorders, emphasizing the importance of diet and microbiota in mental health.
  4. Neuroinflammation and Immune System Interactions:
    The exploration of neuroinflammation as a key player in the pathophysiology of mental disorders is rapidly expanding, with studies linking immune responses to psychiatric symptoms and treatment outcomes.
  5. Personalized and Precision Psychiatry:
    A notable shift towards personalized approaches in psychiatry, incorporating genetic, epigenetic, and environmental factors to tailor interventions based on individual profiles, is becoming increasingly prevalent.
  6. Psychedelic Research:
    Interest in the therapeutic potential of psychedelics for various psychiatric conditions is surging, with studies examining their mechanisms of action, safety, and efficacy in treating depression, PTSD, and other disorders.

Declining or Waning

While "Molecular Psychiatry" continues to expand its focus on emerging areas, certain themes appear to be declining in prominence. These waning scopes reflect shifts in research priorities and advances in understanding psychiatric disorders.
  1. Traditional Psychopharmacology:
    There has been a noticeable decrease in studies centered on traditional pharmacological approaches without integrating molecular mechanisms or genetic insights. The focus is shifting towards personalized medicine and novel therapeutic strategies.
  2. Single-Disorder Studies:
    Research that examines psychiatric disorders in isolation is declining, as there is a growing recognition of the transdiagnostic nature of mental health conditions and the importance of understanding comorbidities.
  3. Behavioral Phenotyping:
    Studies focusing solely on behavioral assessments without molecular or neurobiological correlates are becoming less common, as the field moves towards a more integrated approach that includes genetic and neurobiological perspectives.
  4. Neurotransmitter Models:
    Research heavily reliant on classical neurotransmitter theories (e.g., serotonin, dopamine) without considering the broader neurobiological context is waning, as newer models incorporating neuroinflammation, neuroplasticity, and genetic factors gain traction.

Similar Journals

Frontiers in Psychiatry

Illuminating the Path to Better Mental Health
Publisher: FRONTIERS MEDIA SAISSN: 1664-0640Frequency: 1 issue/year

Frontiers in Psychiatry is a leading journal dedicated to advancing research within the field of psychiatry and mental health. Published by FRONTIERS MEDIA SA, the journal has established a commendable reputation since its inception, reflected in its Q1 status in the 2023 Psychiatry and Mental Health category and a robust ranking of 142 out of 567 in the Scopus database. With an open access model initiated in 2009, Frontiers in Psychiatry aims to disseminate high-quality research to a global audience, fostering collaboration and innovation among researchers, clinicians, and students alike. The journal covers a broad spectrum of topics, including neurobiology, psychosocial factors, treatments, and public health implications of mental disorders, ensuring comprehensive representation of contemporary psychiatric science. Located in Lausanne, Switzerland, and running until 2024, the journal not only emphasizes the importance of mental health research but also encourages interdisciplinary discourse, making it an essential resource for anyone invested in the well-being of individuals and communities alike.

Brain Communications

Advancing Neuroscience Through Open Dialogue
Publisher: OXFORD UNIV PRESSISSN: Frequency: 1 issue/year

Brain Communications is an esteemed, open-access academic journal published by Oxford University Press since 2019, focusing on the dynamic field of neuroscience. With a dedicated ISSN and an E-ISSN of 2632-1297, this journal aims to address the intricate relationships between brain functions, psychiatric disorders, and neurobiological mechanisms. The journal stands out in the academic realm, holding a prestigious Q1 ranking across several categories, including Biological Psychiatry, Cellular and Molecular Neuroscience, Neurology, and Psychiatry and Mental Health for 2023. Notably, it has also secured impressive Scopus ranks in various neuroscience and psychiatry fields, evidencing its commitment to high-quality research. With an impact factor reflective of its growing influence, Brain Communications provides accessible research findings to professionals, researchers, and students alike, fostering a deeper understanding of complex neurological phenomena. This innovative journal is pivotal for anyone involved in advancing knowledge in neuroscience and mental health.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Unveiling the Interdisciplinary Nexus of Mind and Brain
Publisher: SPRINGER HEIDELBERGISSN: 0940-1334Frequency: 6 issues/year

European Archives of Psychiatry and Clinical Neuroscience is a prominent peer-reviewed journal published by Springer Heidelberg, focusing on the interdisciplinary aspects of psychiatry and clinical neuroscience. With an ISSN of 0940-1334 and an E-ISSN of 1433-8491, this journal provides a rigorous platform for innovative research spanning biological psychiatry, pharmacology, and various aspects of mental health. The journal boasts a distinguished impact factor that places it in the Q2 category for Biological Psychiatry and Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health as of 2023, reflecting its significant contribution to the field. Additionally, its Scopus rankings highlight its esteemed position among the top journals, particularly in Medicine and Neuroscience disciplines. Readers can access a wealth of valuable research articles, case studies, and reviews, crucial for advancing understanding and treatment within these vital fields. Initially converged in 1990, the journal continues to evolve and support scholarly dialogue until 2024 and beyond, making it an essential resource for researchers, clinicians, and students alike.

Behavioral and Brain Functions

Advancing the Science of Mind and Behavior
Publisher: BMCISSN: Frequency: 1 issue/year

Behavioral and Brain Functions is a leading Open Access journal published by BMC, dedicated to advancing the field of behavioral neuroscience, cognitive neuroscience, and biological psychiatry since its inception in 2005. This esteemed journal, based in the United Kingdom, has established itself as a vital resource for researchers and professionals, boasting a remarkable influence demonstrated by its Q1 and Q2 rankings across multiple relevant categories. With its commitment to providing unrestricted access to high-quality research, the journal facilitates the dissemination of significant findings in understanding the complex interactions between behavior and brain function. The journal ranks impressively within the Scopus database, positioning itself among the top-tier publications in its categories, making it an essential platform for academic discourse and innovation. As it converges through 2024, Behavioral and Brain Functions continues to play a crucial role in shaping the forefront of neuroscientific inquiry, inviting contributions that challenge our understanding and promote further exploration in these dynamic fields.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Leading the Charge in Psychiatric Science.
Publisher: TAYLOR & FRANCIS LTDISSN: 1562-2975Frequency: 8 issues/year

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, a premier academic journal published by TAYLOR & FRANCIS LTD, stands at the forefront of interdisciplinary research in the fields of Biological Psychiatry, Psychiatry, and Mental Health. Based in the United Kingdom, this esteemed journal (ISSN: 1562-2975; E-ISSN: 1814-1412) has become increasingly influential since its inception in 2000, with a remarkable impact factor that reflects its high-quality research contributions. The journal is consistently ranked in the Q1 and Q2 categories across various relevant indices, demonstrating its reputation for excellence within the academic community. With Scopus rankings placing it in the top 20th percentile for Psychiatry and Mental Health, the WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY serves as a vital resource for researchers, professionals, and students seeking to further their understanding of the intricate relationship between biological processes and psychiatric phenomena. Despite being a traditional access journal, it possesses a robust scope that encompasses groundbreaking studies, reviews, and advancements in the understanding of mental health disorders, underlining its importance as a key reference in the advancement of psychiatric science and therapeutic practices.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Advancing understanding of the mind's intricate workings.
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0149-7634Frequency: 8 issues/year

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, published by PERGAMON-ELSEVIER SCIENCE LTD in the United Kingdom, serves as a leading interdisciplinary platform for the dissemination of pioneering research and reviews in the realms of Neuroscience, Behavioral Neuroscience, Cognitive Neuroscience, and Neuropsychology. With an impressive impact factor reflected in its Q1 ranking across multiple categories for 2023, the journal is recognized for its rigorous peer-reviewed content that influences the advancement of scientific knowledge in behavioral and cognitive research. An essential resource for researchers, professionals, and students alike, the journal emphasizes the exploration of complex neural mechanisms that underlie behavior and cognitive processes. Despite being a subscription-based publication, the journal's extensive archive from 1978 to 2024 fosters a wealth of knowledge designed to inspire and facilitate future advancements within the field.

MOVEMENT DISORDERS

Pioneering Insights into Movement Disorders
Publisher: WILEYISSN: 0885-3185Frequency: 12 issues/year

MOVEMENT DISORDERS, published by Wiley, stands as a premier outlet for cutting-edge research in the field of neurology, particularly focusing on the various aspects of movement disorders. With both its ISSN (0885-3185) and E-ISSN (1531-8257) identifiers, this journal is at the forefront of neurological research, holding a remarkable impact factor and recognized in the top quartiles (Q1) of the disciplines of Neurology and Clinical Neurology as of 2023. The journal boasts an impressive Scopus ranking, placing it in the top 8 out of 192 for Neuroscience-Neprology and 19 out of 400 for Medicine-Clinical Neurology, reflecting its high relevance and influence in the field. Released quarterly since its inception in 1986 and continuing through 2024, MOVEMENT DISORDERS publishes a mix of original research articles, reviews, and case reports that catalyze innovation and foster collaboration among researchers, healthcare professionals, and students dedicated to understanding and treating movement disorders. As a non-open access journal, it nevertheless offers valuable insights that are essential for the advancement of knowledge in neurology, making it a critical resource for anyone invested in this challenging and evolving field.

JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Transforming Knowledge into Clinical Practice
Publisher: CMA-CANADIAN MEDICAL ASSOCISSN: 1180-4882Frequency: 6 issues/year

JOURNAL OF PSYCHIATRY & NEUROSCIENCE, published by the CMA-Canadian Medical Association, serves as a pivotal platform for disseminating cutting-edge research in the fields of psychiatry and neuroscience. This esteemed journal, indexed with the ISSN 1180-4882 and E-ISSN 1488-2434, focuses on advancing our understanding of mental health through meticulous peer-reviewed articles, reviews, and clinical studies. With an impressive impact within the research community, it has achieved notable rankings, including Q1 in both Medicine (miscellaneous) and Psychiatry and Mental Health, as well as Q2 in Biological Psychiatry as of 2023. The journal fosters critical dialogue among scholars and practitioners by offering insights into the complexities of brain function and mental disorders, making it a fundamental resource for healthcare professionals, researchers, and students alike. Although it operates under a subscription model, its rich content continues to inform and influence the advancement of mental health science, affirming its role in bridging the gap between research and clinical practice.

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging

Exploring the Intersection of Mind and Brain
Publisher: ELSEVIERISSN: 2451-9022Frequency: 12 issues/year

Biological Psychiatry-Cognitive Neuroscience and Neuroimaging is a leading interdisciplinary journal published by Elsevier, focusing on the convergence of biological psychiatry, cognitive neuroscience, and advanced neuroimaging techniques. With its prestigious Q1 rankings across essential categories such as Biological Psychiatry, Cognitive Neuroscience, and Neurology (clinical), this journal is at the forefront of research that examines the complexities of mental health through innovative methodologies. Covering a broad spectrum of topics from neurobiological mechanisms to clinical applications, it aims to provide a platform for scholars and practitioners to exchange insights on mental disorders and their neurobiological underpinnings. The impact factor and Scopus rankings further underscore its importance, with rankings highlighting its position in the top percentiles of related disciplines. By fostering an open exchange of ideas and promoting cutting-edge research, this journal is an essential resource for researchers, professionals, and students dedicated to advancements in the understanding and treatment of psychiatric and neurological conditions.

Frontiers in Molecular Neuroscience

Unraveling the complexities of neuroscience, one molecule at a time.
Publisher: FRONTIERS MEDIA SAISSN: 1662-5099Frequency: 1 issue/year

Frontiers in Molecular Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the molecular mechanisms underlying neurological functions and disorders. Since its inception in 2008, the journal has established itself as a reputable source of cutting-edge research, earning a respectable Q2 ranking in both the fields of Cellular and Molecular Neuroscience and Molecular Biology as of 2023. With an ongoing commitment to fostering innovation, the journal presents a platform for researchers, professionals, and students to disseminate their findings and engage in scholarly discourse. The E-ISSN 1662-5099 ensures that research is readily accessible, facilitating the exchange of knowledge crucial to tackling the complexities of neurological conditions. Situated in Switzerland, the journal’s global reach is augmented by its open-access model, allowing for wide dissemination of critical research findings to a diverse audience. Join the vibrant community of scientists and practitioners who are shaping the future of molecular neuroscience through their contributions to this dynamic journal.